Clinical trial / 2010
Inositol and IP6 improved quality of life in breast cancer patients receiving chemotherapy.
Fourteen patients with invasive ductal breast cancer undergoing polychemotherapy were randomized to receive IP6 plus inositol or placebo. Participants taking the supplement maintained leukocyte and platelet counts without cytopenia, whereas red blood cell counts and tumor markers did not differ between arms. Supplementation resulted in significantly higher functional status (p = 0.0003) and overall quality of life scores (p = 0.05).
- Study type
- Randomized controlled trial
- Who was studied
- 14 patients with invasive ductal breast cancer receiving chemotherapy
- What was measured
- Quality of life, blood cell counts, and tumor markers
THE PAPER
Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical study.
Bacić I, Druzijanić N, Karlo R, Skifić I, Jagić S. J Exp Clin Cancer Res, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.